PTPN11 and non-small cell lung carcinoma: Abnormally high expression of SHP2 enhances NSCLC cell proliferation, migration and invasion, and inhibition or knockdown of SHP2 impedes the A549 epithelial–mesenchymal transition (EMT) [27,28].